Tumor radiosensitivity: It's the subpopulations that count

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 3, 2000, Pages 549-550

  Brown, J M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CISPLATIN; TIRAPAZAMINE;

CANCER CONTROL; CANCER RADIOTHERAPY; CELL KILLING; EDITORIAL; HYPERTHERMIA; PRIORITY JOURNAL; RADIATION INJURY; RADIOSENSITIVITY; SOLID TUMOR;

EID: 0034213466     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00478-8     Document Type: Editorial

References (5)

1. M. Nordsmark M. Overgaard J. Overgaard Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother Oncol 41 1996 31 40
2. A.W. Fyles M. Milosevic R. Wong Oxygenation predicts radiation response and survival in patients with cervix cancer Radiother Oncol 48 1998 149 156
3. R.E. Durand The influence of microenvironmental factors during cancer therapy In vivo 8 1994 691 702
4. S. Masunaga K. Ono Y. Nishimura Combined effects of tirapazamine and mild hyperthermia on antiangiogenic agent (TNP-470) treated tumors Reference to the effect on intratumor quiescent cells Int J Radiat Oncol Biol Phys 47 2000 799 807
5. M.S. Kovacs D.J. Hocking J.W. Evans Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin Br J Cancer 80 1999 1245 1251